Stocks
Amgen Inc. Loses Shareholder Confidence Amid Revenue Growth
Corient Private Wealth LP decreased its position in shares of Amgen Inc. (NASDAQ:AMGN) by 15.3% during the second quarter, according to its latest Form 13F filing with the Securities and Exchange Commission.
The fund sold 84,082 shares during the period, reducing its ownership to 466,785 shares of the medical research company's stock.
This move decreased Corient Private Wealth LP's stake in Amgen by about 0.09% of the company's total value, which is approximately $169 million at the end of the most recent reporting period.